- Home
- GROV vs MIRA Comparison
GROV vs MIRA Comparison
Compare GROV & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GROV | MIRA |
|---|---|---|
| Founded | 2016 | 2020 |
| Country | United States | United States |
| Employees | 415 | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.4M | 53.2M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | GROV | MIRA |
|---|---|---|
| Price | $1.34 | $0.91 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $1.60 | N/A |
| AVG Volume (30 Days) | 75.4K | ★ 139.3K |
| Earning Date | 03-05-2026 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.31 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.81 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.02 | $0.81 |
| 52 Week High | $1.66 | $2.45 |
Technical Indicators
Market Signals| Indicator | GROV | MIRA |
|---|---|---|
| Relative Strength Index (RSI) | 50.56 | 22.61 |
| Support Level | $1.29 | N/A |
| Resistance Level | $1.46 | $1.28 |
| Average True Range (ATR) | 0.07 | 0.08 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 70.59 | 0.00 |
Price Performance
Historical ComparisonAbout GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.